ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| RESMED, Inc. (NYSE: RMD) | Delayed: 222.86 +3.97 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.89 | 52 Week High | $70.90 | |||
| Open | $218.44 | 52 Week Low | $50.77 | |||
| Day High | $223.72 | P/E | 99.94 | |||
| Day Low | $218.44 | EPS | $2.23 | |||
| Volume | 952,067 | |||||
| Resmed, Inc. (AMEX: RSMDF) | Delayed: 22.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.61 | 52 Week High | $6.68 | |||
| Open | $22.61 | 52 Week Low | $5.13 | |||
| Day High | $22.61 | P/E | N/A | |||
| Day Low | $22.61 | EPS | $0.00 | |||
| Volume | 17 | |||||
